1 | future | 18,146 |
2 | long-run | 9 |
3 | empirical-ethical | 8 |
4 | asian-dominant | 6 |
5 | mg17 | 6 |
6 | near-future | 6 |
7 | repetitive/constrained | 6 |
8 | substance-dependence | 5 |
9 | basic-science | 4 |
10 | biomark | 4 |
11 | netc | 4 |
12 | rheumatology-osteoarthritis | 4 |
13 | steps-up | 4 |
14 | a-top | 3 |
15 | air-pollution | 3 |
16 | eurobservational | 3 |
17 | human-subjects | 3 |
18 | initial-sprint | 3 |
19 | isrctn80309252 | 3 |
20 | mikołajki | 3 |
21 | nonconflict | 3 |
22 | paleodiet | 3 |
23 | solution-oriented | 3 |
24 | well-intended | 3 |
25 | 'perioperative | 2 |
26 | cataloging | 2 |
27 | client-reported | 2 |
28 | clinical-therapeutic | 2 |
29 | dimethaid | 2 |
30 | empangeni | 2 |
31 | ge/as01e | 2 |
32 | hgf-stat | 2 |
33 | m.v.d | 2 |
34 | ms-directed | 2 |
35 | multi-environmental | 2 |
36 | nandurbar | 2 |
37 | neurotransplantation | 2 |
38 | nonpivotal | 2 |
39 | novalung® | 2 |
40 | ounianga | 2 |
41 | pono | 2 |
42 | rheumatology/osteoarthritis | 2 |
43 | surrogate-based | 2 |
44 | team-related | 2 |
45 | thrasher | 2 |
46 | toxicogenetic | 2 |
47 | westward | 2 |
48 | 'large-scale | 1 |
49 | 'scientifically-based | 1 |
50 | 'translational | 1 |
51 | 0.999999 | 1 |
52 | 30k | 1 |
53 | 49,184 | 1 |
54 | 6,944 | 1 |
55 | access-to-treatment | 1 |
56 | agrobiodiversity | 1 |
57 | aids/azt | 1 |
58 | alternate/combination | 1 |
59 | analysis.eight | 1 |
60 | anti-free-will | 1 |
61 | atari | 1 |
62 | barabas | 1 |
63 | basical | 1 |
64 | bench-based | 1 |
65 | better-directed | 1 |
66 | biases.seven | 1 |
67 | biomacromolecule | 1 |
68 | blm-mediated | 1 |
69 | brain-behavioral | 1 |
70 | budding-site | 1 |
71 | c6orf204 | 1 |
72 | cardiac-based | 1 |
73 | cbe-controlled | 1 |
74 | climate-health | 1 |
75 | clinical-endpoint | 1 |
76 | clinical/translational | 1 |
77 | cluster-analytic | 1 |
78 | colearning | 1 |
79 | consumer-led | 1 |
80 | delirium.further | 1 |
81 | down-coast | 1 |
82 | electric-utility-related | 1 |
83 | eligibility.thirteen | 1 |
84 | exposure-controlled | 1 |
85 | fractures.four | 1 |
86 | future/subsequent | 1 |
87 | gambling-treatment | 1 |
88 | genetics/cancer | 1 |
89 | genome-enabled | 1 |
90 | hbig-free | 1 |
91 | heterogeneity.while | 1 |
92 | hiv-efficacy | 1 |
93 | hmgs-related | 1 |
94 | hsp90-driven | 1 |
95 | hyaluronic-acid-related | 1 |
96 | implementation/dissemination | 1 |
97 | inclusion.two | 1 |
98 | kinesiological | 1 |
99 | late-arriving | 1 |
100 | life.pediatric | 1 |
101 | mechanistic-based | 1 |
102 | mechnikov | 1 |
103 | mitocare | 1 |
104 | multicentre-controlled | 1 |
105 | multiuse | 1 |
106 | mult‑target | 1 |
107 | nanopesticide | 1 |
108 | neurodietary | 1 |
109 | niaid-sponsored | 1 |
110 | nonprotocol-driven | 1 |
111 | nurse-authored | 1 |
112 | observational/interventional | 1 |
113 | operator-which | 1 |
114 | paleomicrobiological | 1 |
115 | pharmacometabolomics | 1 |
116 | poorly-devised | 1 |
117 | post-alendronate | 1 |
118 | practiceno | 1 |
119 | present/future | 1 |
120 | psycho-physiologic | 1 |
121 | psychohematology | 1 |
122 | radiumhemmet | 1 |
123 | rakovník | 1 |
124 | ranomafana | 1 |
125 | replicatory | 1 |
126 | rhodern | 1 |
127 | robustly-designed | 1 |
128 | scania | 1 |
129 | settings.eligible | 1 |
130 | staff-focused | 1 |
131 | technique-focused | 1 |
132 | tejgaon | 1 |
133 | threshold-free | 1 |
134 | tongue-related | 1 |
135 | ukclinical | 1 |
136 | universal/academic | 1 |
137 | us-more | 1 |
138 | utero.further | 1 |
139 | vt-related | 1 |
140 | vvpilot | 1 |
1 | 'large-scale | 1 |
2 | 'perioperative | 2 |
3 | 'scientifically-based | 1 |
4 | 'translational | 1 |
5 | 0.999999 | 1 |
6 | 30k | 1 |
7 | 49,184 | 1 |
8 | 6,944 | 1 |
9 | a-top | 3 |
10 | access-to-treatment | 1 |
11 | agrobiodiversity | 1 |
12 | aids/azt | 1 |
13 | air-pollution | 3 |
14 | alternate/combination | 1 |
15 | analysis.eight | 1 |
16 | anti-free-will | 1 |
17 | asian-dominant | 6 |
18 | atari | 1 |
19 | barabas | 1 |
20 | basic-science | 4 |
21 | basical | 1 |
22 | bench-based | 1 |
23 | better-directed | 1 |
24 | biases.seven | 1 |
25 | biomacromolecule | 1 |
26 | biomark | 4 |
27 | blm-mediated | 1 |
28 | brain-behavioral | 1 |
29 | budding-site | 1 |
30 | c6orf204 | 1 |
31 | cardiac-based | 1 |
32 | cataloging | 2 |
33 | cbe-controlled | 1 |
34 | client-reported | 2 |
35 | climate-health | 1 |
36 | clinical-endpoint | 1 |
37 | clinical-therapeutic | 2 |
38 | clinical/translational | 1 |
39 | cluster-analytic | 1 |
40 | colearning | 1 |
41 | consumer-led | 1 |
42 | delirium.further | 1 |
43 | dimethaid | 2 |
44 | down-coast | 1 |
45 | electric-utility-related | 1 |
46 | eligibility.thirteen | 1 |
47 | empangeni | 2 |
48 | empirical-ethical | 8 |
49 | eurobservational | 3 |
50 | exposure-controlled | 1 |
51 | fractures.four | 1 |
52 | future | 18,146 |
53 | future/subsequent | 1 |
54 | gambling-treatment | 1 |
55 | ge/as01e | 2 |
56 | genetics/cancer | 1 |
57 | genome-enabled | 1 |
58 | hbig-free | 1 |
59 | heterogeneity.while | 1 |
60 | hgf-stat | 2 |
61 | hiv-efficacy | 1 |
62 | hmgs-related | 1 |
63 | hsp90-driven | 1 |
64 | human-subjects | 3 |
65 | hyaluronic-acid-related | 1 |
66 | implementation/dissemination | 1 |
67 | inclusion.two | 1 |
68 | initial-sprint | 3 |
69 | isrctn80309252 | 3 |
70 | kinesiological | 1 |
71 | late-arriving | 1 |
72 | life.pediatric | 1 |
73 | long-run | 9 |
74 | m.v.d | 2 |
75 | mechanistic-based | 1 |
76 | mechnikov | 1 |
77 | mg17 | 6 |
78 | mikołajki | 3 |
79 | mitocare | 1 |
80 | ms-directed | 2 |
81 | multi-environmental | 2 |
82 | multicentre-controlled | 1 |
83 | multiuse | 1 |
84 | mult‑target | 1 |
85 | nandurbar | 2 |
86 | nanopesticide | 1 |
87 | near-future | 6 |
88 | netc | 4 |
89 | neurodietary | 1 |
90 | neurotransplantation | 2 |
91 | niaid-sponsored | 1 |
92 | nonconflict | 3 |
93 | nonpivotal | 2 |
94 | nonprotocol-driven | 1 |
95 | novalung® | 2 |
96 | nurse-authored | 1 |
97 | observational/interventional | 1 |
98 | operator-which | 1 |
99 | ounianga | 2 |
100 | paleodiet | 3 |
101 | paleomicrobiological | 1 |
102 | pharmacometabolomics | 1 |
103 | pono | 2 |
104 | poorly-devised | 1 |
105 | post-alendronate | 1 |
106 | practiceno | 1 |
107 | present/future | 1 |
108 | psycho-physiologic | 1 |
109 | psychohematology | 1 |
110 | radiumhemmet | 1 |
111 | rakovník | 1 |
112 | ranomafana | 1 |
113 | repetitive/constrained | 6 |
114 | replicatory | 1 |
115 | rheumatology-osteoarthritis | 4 |
116 | rheumatology/osteoarthritis | 2 |
117 | rhodern | 1 |
118 | robustly-designed | 1 |
119 | scania | 1 |
120 | settings.eligible | 1 |
121 | solution-oriented | 3 |
122 | staff-focused | 1 |
123 | steps-up | 4 |
124 | substance-dependence | 5 |
125 | surrogate-based | 2 |
126 | team-related | 2 |
127 | technique-focused | 1 |
128 | tejgaon | 1 |
129 | thrasher | 2 |
130 | threshold-free | 1 |
131 | tongue-related | 1 |
132 | toxicogenetic | 2 |
133 | ukclinical | 1 |
134 | universal/academic | 1 |
135 | us-more | 1 |
136 | utero.further | 1 |
137 | vt-related | 1 |
138 | vvpilot | 1 |
139 | well-intended | 3 |
140 | westward | 2 |
1 | isrctn80309252 | 3 |
2 | c6orf204 | 1 |
3 | 6,944 | 1 |
4 | 49,184 | 1 |
5 | mg17 | 6 |
6 | 0.999999 | 1 |
7 | ounianga | 2 |
8 | scania | 1 |
9 | ranomafana | 1 |
10 | psycho-physiologic | 1 |
11 | universal/academic | 1 |
12 | life.pediatric | 1 |
13 | toxicogenetic | 2 |
14 | clinical-therapeutic | 2 |
15 | cluster-analytic | 1 |
16 | netc | 4 |
17 | m.v.d | 2 |
18 | well-intended | 3 |
19 | consumer-led | 1 |
20 | genome-enabled | 1 |
21 | cbe-controlled | 1 |
22 | multicentre-controlled | 1 |
23 | exposure-controlled | 1 |
24 | robustly-designed | 1 |
25 | repetitive/constrained | 6 |
26 | nurse-authored | 1 |
27 | niaid-sponsored | 1 |
28 | cardiac-based | 1 |
29 | mechanistic-based | 1 |
30 | surrogate-based | 2 |
31 | bench-based | 1 |
32 | 'scientifically-based | 1 |
33 | poorly-devised | 1 |
34 | technique-focused | 1 |
35 | staff-focused | 1 |
36 | blm-mediated | 1 |
37 | hyaluronic-acid-related | 1 |
38 | tongue-related | 1 |
39 | team-related | 2 |
40 | hmgs-related | 1 |
41 | vt-related | 1 |
42 | electric-utility-related | 1 |
43 | better-directed | 1 |
44 | ms-directed | 2 |
45 | solution-oriented | 3 |
46 | client-reported | 2 |
47 | dimethaid | 2 |
48 | westward | 2 |
49 | ge/as01e | 2 |
50 | substance-dependence | 5 |
51 | basic-science | 4 |
52 | nanopesticide | 1 |
53 | threshold-free | 1 |
54 | hbig-free | 1 |
55 | 'large-scale | 1 |
56 | settings.eligible | 1 |
57 | heterogeneity.while | 1 |
58 | biomacromolecule | 1 |
59 | mitocare | 1 |
60 | us-more | 1 |
61 | future | 18,146 |
62 | near-future | 6 |
63 | present/future | 1 |
64 | multiuse | 1 |
65 | post-alendronate | 1 |
66 | budding-site | 1 |
67 | 'perioperative | 2 |
68 | cataloging | 2 |
69 | colearning | 1 |
70 | late-arriving | 1 |
71 | operator-which | 1 |
72 | climate-health | 1 |
73 | mikołajki | 3 |
74 | empangeni | 2 |
75 | atari | 1 |
76 | 30k | 1 |
77 | biomark | 4 |
78 | rakovník | 1 |
79 | paleomicrobiological | 1 |
80 | kinesiological | 1 |
81 | empirical-ethical | 8 |
82 | ukclinical | 1 |
83 | basical | 1 |
84 | 'translational | 1 |
85 | clinical/translational | 1 |
86 | eurobservational | 3 |
87 | observational/interventional | 1 |
88 | brain-behavioral | 1 |
89 | multi-environmental | 2 |
90 | nonpivotal | 2 |
91 | anti-free-will | 1 |
92 | eligibility.thirteen | 1 |
93 | biases.seven | 1 |
94 | hsp90-driven | 1 |
95 | nonprotocol-driven | 1 |
96 | tejgaon | 1 |
97 | alternate/combination | 1 |
98 | implementation/dissemination | 1 |
99 | neurotransplantation | 2 |
100 | air-pollution | 3 |
101 | rhodern | 1 |
102 | long-run | 9 |
103 | practiceno | 1 |
104 | pono | 2 |
105 | inclusion.two | 1 |
106 | a-top | 3 |
107 | steps-up | 4 |
108 | nandurbar | 2 |
109 | genetics/cancer | 1 |
110 | thrasher | 2 |
111 | delirium.further | 1 |
112 | utero.further | 1 |
113 | fractures.four | 1 |
114 | barabas | 1 |
115 | pharmacometabolomics | 1 |
116 | rheumatology-osteoarthritis | 4 |
117 | rheumatology/osteoarthritis | 2 |
118 | human-subjects | 3 |
119 | hgf-stat | 2 |
120 | nonconflict | 3 |
121 | mult‑target | 1 |
122 | paleodiet | 3 |
123 | radiumhemmet | 1 |
124 | analysis.eight | 1 |
125 | asian-dominant | 6 |
126 | gambling-treatment | 1 |
127 | access-to-treatment | 1 |
128 | future/subsequent | 1 |
129 | clinical-endpoint | 1 |
130 | initial-sprint | 3 |
131 | vvpilot | 1 |
132 | down-coast | 1 |
133 | aids/azt | 1 |
134 | mechnikov | 1 |
135 | hiv-efficacy | 1 |
136 | psychohematology | 1 |
137 | neurodietary | 1 |
138 | replicatory | 1 |
139 | agrobiodiversity | 1 |
140 | novalung® | 2 |